Addressing Industry Challenges In Cell And Gene Therapy Supply Chain Through Global, Integrated Solutions

The success of cell and gene therapies not only depends on clinical efficacy, but also managing the complex supply chain required to get these novel products to patients. There are many factors to consider when building a flexible and scalable supply chain, including sample collection, ultra-cold and cryogenic storage, documentation and tracking requirements, communication and vender management, regulatory guidelines and more.

Thermo Fisher Scientific has extensive experience in executing complex supply chain solutions from clinical trials through commercialization for a variety of biological product types. This informative webinar shares insights from industry experts to help you mitigate supply chain risk and accelerate access to new therapies.

Key learning objectives:

• How to address unique challenges for CGT supply chain with a focus on traceability and ultra-cold storage requirements
• Impact of regional regulatory requirements for CGT products including global considerations
• Lessons learned/best practices to mitigate risk in your supply chain and accelerate the path from clinic to commercialization
• Benefits of leveraging an integrated services model across entire manufacturing lifecycle and supply chain